Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
Verlagsversion
DOI
 |
Open Access Gold |
|
möglich sobald bei der ZB eingereicht worden ist.
Targeting IgE in severe atopic dermatitis with a combination of immunoadsorption and omalizumab.
Acta Derm.-Venereol. 96, 72-76 (2016)
Patients with atopic dermatitis (AD) tend to have greatly elevated levels of serum immunoglobulin E (IgE). However, the role of IgE in the pathogenesis of AD is debated. This investigator-initiated open-label pilot study evaluates an anti-IgE-treatment approach by combining extracorporeal immunoadsorption and anti-IgE antibody omalizumab in 10 patients with severe, therapy-refractory AD. IgE levels decreased after immunoadsorption and decreased continuously in all patients during anti-IgE therapy. The reverse trend was observed during 6 months follow-up without treatment. In parallel with these observations, an improvement in AD was observed during the treatment period, with aggravation during follow-up. Further research is needed, based on the principle of reducing IgE levels in order to improve clinical symptoms, using a combination anti-IgE treatment approach, adjusted according to IgE levels.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Atopic Dermatitis ; Atopic Eczema ; Immunoglobulin E ; Ige ; Immunoadsorption ; Omalizumab ; Anti-ige-treatment; Activation-regulated Chemokine; Food Allergy; Liver-transplantation; Therapy; Disease; Urticaria; Efficacy; Thymus
ISSN (print) / ISBN
0001-5555
e-ISSN
1651-2057
Zeitschrift
Acta Dermato-Venereologica
Quellenangaben
Band: 96,
Heft: 1,
Seiten: 72-76
Verlag
Acta Dermato-Venereologica
Verlagsort
Uppsala
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute for Allergy Research (IAF)